Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model

This study evaluates a short therapy schedule for bladder cancer using BCG Tokyo. BCG Tokyo was evaluated in vitro using bone marrow derived dendritic cells, neutrophils, RAW macrophages and the murine bladder cancer cell line, MB49PSA, and compared to other BCG strains. BCG Tokyo > BCG TICE at i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tham, Sin Mun, Rahmat, Juwita N., Chiong, Edmund, Wu, Qinghui, Esuvaranathan, Kesavan, Mahendran, Ratha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698822/
https://www.ncbi.nlm.nih.gov/pubmed/34944584
http://dx.doi.org/10.3390/biomedicines9121766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698822/
https://www.ncbi.nlm.nih.gov/pubmed/34944584
http://dx.doi.org/10.3390/biomedicines9121766

Ejemplares similares